Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$2.12 USD
+0.08 (3.92%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $2.13 +0.01 (0.47%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.19 | 10.53% |
Earnings Summary
For their last quarter, Mersana Therapeutics (MRSN) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.18 per share. This reflects a negative earnings surprise of 11.11%. Look out for MRSN's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 45.71%.
Earnings History
Price & Consensus
Zacks News for MRSN
Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates
MRSN: What are Zacks experts saying now?
Zacks Private Portfolio Services